They showed that patients suffer from TB as a result of either a failed or an excessive immune response to the mycobacterial infection, and that only the subset of TB meningitis patients with an excessive response, showing a hyperinflammatory phenotype (in their study as a result of a polymorphism in the LTA4H gene), benefited from adjunctive GC therapy. The gene discussed is LTA4H; the disease is meningitis.